Aventis Settles Suit Over Allegra Patent

Aventis Pharmaceuticals Inc. has reached a settlement to end its long-running suit accusing several generic-drug makers of infringing patents for allergy drug Allegra, according to an order filed Tuesday in New...

Already a subscriber? Click here to view full article